GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kyverna Therapeutics KYTX · USD

N/A · US listing · 🇺🇸 United States

Compare

5.17

+5.94%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Largest shareholders

As filed, so dates differ, and a group and its funds can both appear.

HolderSharesStakeChangeFiled
VV Manager LLC4.5m7.92%—30 Jun 2025
Gilead Sciences Inc4.1m7.22%—30 Jun 2025
Bain Capital Life Sciences Investors, LLC3.4m5.90%—30 Jun 2025
T. Rowe Price Associates, Inc.1.8m3.11%+1.2m30 Jun 2025
The Vanguard Group, Inc.1.3m2.30%+14.3k30 Jun 2025
Insight Venture Partners989.1k1.73%—30 Jun 2025
Medical Strategy GmbH693.2k1.21%+60k31 Jul 2025
Franklin Advisers, Inc.692k1.21%—30 Jun 2025
MBB Public Markets I LLC614.5k1.08%—30 Jun 2025
Catalio Capital Management, LP586.9k1.03%—30 Jun 2025
BlackRock Institutional Trust Company, N.A.490.7k0.86%−1m30 Jun 2025
Millennium Management LLC452.6k0.79%+214.3k30 Jun 2025
Kera Capital Partners, Inc.421.9k0.74%—30 Sept 2025
Peapod Lane Capital LLC396.8k0.69%+54230 Jun 2025
Citadel Advisors LLC325.4k0.57%−668.2k30 Jun 2025

Short interest

Shares sold short, 15 Oct 2026. US exchange data.

9.5m

-0.8% on the period before. 10.5 days to cover.

Short volume

Share of the day's trading sold short, 4 Nov 2026

29.8%

Last 60 trading days.

Failed deliveries

Shares not delivered on settlement, from the SEC

  • 30 Sept 20264,810 shares
  • 29 Sept 20261,780 shares
  • 23 Sept 2026184 shares
  • 15 Sept 20262,115 shares
  • 10 Sept 20261,360 shares

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.